Researchers discovered that a new pill shows promising results in improving levels of cholesterol, triglycerides and other lipids that can be related to risk of heart disease. During the study patients were treated with Simcor combination and they felt improvement in reduction of non HDL , HDL and triglyceride levels. Simcor represents a combination of niacin and simvastatin and it has ability to target good cholesterol (HDL), bad cholesterol (LDL) and triglyceride. Drug called Niacin raises levels of HDL and Statins reduces levels of LDL cholesterol and triglycerides.

In the study one group of patients received Simcor combination which contained 20mg of simvastatin and the other group received simvastatin therapy only. It was discovered that first group had significantly greater reductions of non HDL, HDL and triglyceride when compared to the other group. Also, patients who received Simcor combination with 40 mg simvastatin had better reductions in reducing levels of non HDL, HDL and triglyceride in comparation with the ones who took 80mg high dose of simvastatin alone.

Results clearly indicate that Simcor combination is better than simvastatin therapy alone and this finding can lead to better treatments for patients diagnosed with complex lipid disorders, metabolic syndrome and heart disease.